HUNTINGTON MEDICAL RESEARCH INSTITUTES

HMRI researchers reduced stroke size by 74% using empagliflozin, an antidiabetic drug, in preclinical models, presenting findings at AHA Scientific Sessions. The study suggests potential preventive and acute treatment applications for high-risk individuals, though further research is needed.